Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract

Allergy and Asthma Proceedings

Volumn 28, Issue 3, 2007, Pages 324-330

  Capetandes, Anthony ^a   Zhuang, Minsheng ^a   Haque, Farah N ^a   Xie, Linjun ^a   Frieri, Marianne ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveoli; Asthma; Dermatophagoides; Fibroblasts; VEGF

Indexed keywords

HOUSE DUST ALLERGEN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ARTICLE; ASTHMA; CELL CULTURE; CULTURE MEDIUM; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG; METABOLISM; SECRETION;

ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34447285024     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.2999     Document Type: Article

References (38)

1. Frieri M. Airway epithelial cell release of cytokines-modulation by various therapeutic agents. Allergy Asthma Proc 25:387-393, 2004.
2. Kay AB, Phipps S, and Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 25:477-482, 2004.
3. Davies DE, Wicks J, Powell RM, et al. Airway remodeling in asthma: New insights. J Allergy Clin Immunol 111:215-225, 2003.
4. Xu YD, Hua J, Mui A, et al. Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 285:L527-L539, 2003.
5. Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111:1293-1298, 2003.
6. Wen FQ, Liu X, Manda W, et al. TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. J Allergy Clin Immunol 111:1307-1318, 2003.
7. Hoshino M, Takahashi M, and Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107:295-301, 2001.
8. Richter A, Puddicombe SM, Lordan JL, et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 25:385-391, 2001.
9. Asai K, Kanazawa H, Kamoi H, et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 33:595-599, 2003.
10. Lee CG, Link H, Baluk P, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095-1103, 2004.
11. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:S39-S45, 2001.
12. Kobayashi T, Liu X, Wen FQ, et al. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun 327:393-398, 2005.
13. Huang YQ, Li JJ, Hu L, et al. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 86:1094-1098, 2001.
14. Asokananthan N, Graham PT, Stewart DJ, et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: The cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 169:4572-4578, 2002.
15. Phipps S, Benyahia F, Ou TT, et al. Acute allergen-induced airway remodeling in atopic asthma. Am. J. Respir. Cell Mol. Biol. 31:626-632, 2004.
16. Wan H, Winton HL, Soeller C, et al. Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1. Clin Exp Allergy 30:685-698, 2000.
17. Winton HL, Wan H, Cannell MB, et al. Class specific inhibition of house dust mite proteinases which cleave cell adhesion, induce cell death and which increase the permeability of lung epithelium. Br J Pharmacol 124:1048-1059, 1998.
18. Shahana S, Kampf C, and Roomans GM. Effects of the cationic protein poly-L-arginine on airway epithelial cells in vitro. Mediators Inflamm 11:141-148, 2002.
19. Jarman ER, and Lamb JR. Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling. Immunology 112:631-642, 2004.
20. Kraft M, Martin RJ, Wilson S, et al. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 159:228-234, 1999.
21. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 154:1505-1510, 1996.
22. Heiman AS, Abonyo BO, Darling-Reed SF, et al. Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26). J Interferon Cytokine Res 25:82-91, 2005.
23. Lieber M, Smith B, Szakal A, et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62-70, 1976.
24. Winton HL, Wan H, Cannell MB, et al. Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite particles proteinases on the regulation of epithelial permeability. Clin Exp Allergy 28:1273-1285, 1998.
25. Elia C, Bucca C, Rolla G, et al. A freeze-fracture study of human bronchial epithelium in normal, bronchitic and asthmatic subjects. J Submicrosc Cytol Pathol 20:509-517, 1988.
26. Capetandes A, Horne NS, and Frieri M. Dermatophagoides extract-treated confluent type II epithelial cells (cA549) and human lung mesenchymal cell growth. Ann Allergy Asthma Immunol 95:381-388, 2005.
27. Huang YC, Leyko B, Frieri M. Effects of omalizumab and budesonide on markers of inflammation in human bronchial cells. Ann Allergy Asthma Immunol 95:443-451, 2005.
28. Capetandes A, Xie L, Huang YC, and Frieri M. Dust mite allergen and IL1β stimulates human pulmonary alveolar cells (A549) to secrete VEGF. J Allergy Clin Immunol 133:3192, 2004 (Abs 666).
29. Hacena M, May B, Courtney S, et al. Il-8, TGFβ, GMCSF, production from ragweed and dust mite stimulated pulmonary epithelial cells with budesonide. Ann Allergy Asthma Immunol 90:79a, 2003.
30. Horne NS, Shaw H, Frieri M. Modulation of IL-8, mRNA expression and production in respiratory syncytial virus (RSV)-stimulated human alveolar epithelial cells by budesonide and montelukast. J Allergy Clin Immunol 113:8192, 2004.
31. Boussat S, Eddahibi S, Coste A, et al. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 279:L371-L378, 2000.
32. Koyama S, Sato E, Tsukadaira A, et al. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J 20:1449-1456, 2002.
33. Bandi N, and Kompella UB. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol 425:109-116, 2001.
34. Kaner RJ, and Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 7:240-246, 2001.
35. Frieri M. Asthma concepts in the new millennium: Update in asthma pathophysiology. Allergy Asthma Proc 26:83-88, 2005.
36. Ma L, Perini R, McKnight W, et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 102:216-220, 2005.
37. Caunt M, Huang YQ, Brooks PC, et al. Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost 1:2078-2080, 2003.
38. Frieri M. Inflammatory issues in allergic rhinitis and asthma. Allergy Asthma Proc 261:26, 2005.